Regen BioPharma Inc (RGBP)

[LaddyMan]

From today: Only a nice endorsement from a new client of Objective Capital in our space.

CardioCell joins Objective Capital's roster of biotechnology and life science clients, including public companies Marina Biotech and Regen Biopharma and several privately held enterprises. The Objective Capital team has extensive experience in the life science space working with companies on strategic advisory, sell- and buy-side engagements, licensing, valuation and capital funding efforts.

"Objective Capital has an exceptional understanding of the market opportunity for stem cell technology, and we are pleased to partner together as CardioCell enters an accelerated growth cycle," says Sergey Sikora, CEO of CardioCell.

RGBP